These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10037105)

  • 1. Estrogen replacement therapy and breast cancer survival in a large screening study.
    Schairer C; Gail M; Byrne C; Rosenberg PS; Sturgeon SR; Brinton LA; Hoover RN
    J Natl Cancer Inst; 1999 Feb; 91(3):264-70. PubMed ID: 10037105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
    LeBlanc ES; Viscoli CM; Henrich JB
    J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic use of hormone therapy and mortality after breast cancer.
    Newcomb PA; Egan KM; Trentham-Dietz A; Titus-Ernstoff L; Baron JA; Hampton JM; Stampfer MJ; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):864-71. PubMed ID: 18381475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.
    Holli K; Isola J; Cuzick J
    J Clin Oncol; 1998 Sep; 16(9):3115-20. PubMed ID: 9738583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
    Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
    J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
    Laya MB; Larson EB; Taplin SH; White E
    J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.
    Sener SF; Winchester DJ; Winchester DP; Du H; Barrera E; Bilimoria M; Krantz S; Rabbitt S
    Am J Surg; 2009 Mar; 197(3):403-7. PubMed ID: 19245923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study.
    Barron TI; Flahavan EM; Sharp L; Bennett K; Visvanathan K
    Cancer Res; 2014 Aug; 74(15):4065-77. PubMed ID: 25085874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer diagnosed during hormone replacement therapy.
    Gajdos C; Tartter PI; Babinszki A
    Obstet Gynecol; 2000 Apr; 95(4):513-8. PubMed ID: 10725482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of axillary lymph node metastasis in primary breast cancer.
    Jatoi I; Hilsenbeck SG; Clark GM; Osborne CK
    J Clin Oncol; 1999 Aug; 17(8):2334-40. PubMed ID: 10561295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk: effects of estrogen replacement therapy and body mass.
    Harris RE; Namboodiri KK; Wynder EL
    J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between breast cancer survival and prior postmenopausal estrogen use.
    Strickland DM; Gambrell RD; Butzin CA; Strickland K
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):400-4. PubMed ID: 1495695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Bradley MC; Black A; Freedman AN; Barron TI
    Cancer; 2016 Jul; 122(13):2067-75. PubMed ID: 27149646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic characteristics in breast cancers after hormone replacement therapy.
    Magnusson C; Holmberg L; Nordén T; Lindgren A; Persson I
    Breast Cancer Res Treat; 1996; 38(3):325-34. PubMed ID: 8739086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.